Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma

被引:1
作者
Usmani, Saad [1 ]
Weiss, Brendan [2 ,3 ]
Bahlis, Nizar J. [4 ]
Belch, Andrew [5 ]
Lonial, Sagar [6 ]
Lokhorst, Henk [7 ]
Voorhees, Peter M. [8 ]
Richardson, Paul G. [9 ]
Sasser, A. Kate [10 ]
Axel, Amy [10 ]
Feng, Huaibao [11 ]
Uhlar, Clarissa [10 ]
Wang, Jianping [10 ]
Khan, Imran [10 ]
Ahmadi, Tahamtan [10 ]
Nahi, Hareth [12 ]
机构
[1] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[5] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[6] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA
[7] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands
[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[9] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA
[10] Janssen Res & Dev LLC, Spring House, PA USA
[11] Janssen Res & Dev LLC, Raritan, NJ USA
[12] Karolinska Inst, Dept Med, Div Hematol, Karolinska Univ Hosp Huddinge, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
empty
未找到相关数据